Volatility means opportunity! Watch price changes reflect directly onto your portfolio
Get the facts about trading GW Pharmaceuticals Plc before you start. Discuss investment strategies, review market research, and get real-time updates
612,850 GW Pharmaceuticals Plc positions opened on eToro
GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, UK. It is a biopharmaceutical company, which is currently focused on developing and marketing cannabinoid-based medicines for a range of disease areas. Key products include Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD), and Sativex (nabiximols), which is used for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Follow the GWPH instrument to learn all about the latest news and developments.
Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.